# TINF2

## Overview
The TINF2 gene encodes the TERF1-interacting nuclear factor 2 (TIN2) protein, a pivotal component of the shelterin complex, which is integral to telomere maintenance and protection in human cells. TIN2 is classified as a telomere-associated protein and plays a crucial role in stabilizing telomeres by mediating interactions between double-stranded DNA-binding proteins TRF1 and TRF2, and the single-stranded DNA-binding protein POT1, via the intermediary protein TPP1. This interaction is essential for the assembly and function of the shelterin complex, ensuring telomere integrity and preventing chromosomal instability (Khakzad2023A; Savage2008TINF2). TIN2 also regulates telomerase activity, enhancing its processivity to maintain telomere length, and is involved in telomere replication and replication fork progression (Pike2019TIN2). Mutations in TINF2 are linked to telomere biology disorders and various cancers, highlighting its clinical significance (Revy2022Genetics; Schmutz2020TINF2).

## Function
The TINF2 gene encodes the TIN2 protein, a crucial component of the shelterin complex, which is essential for telomere maintenance and protection in human cells. TIN2 plays a central role in stabilizing telomeres by connecting the double-stranded DNA-binding proteins TRF1 and TRF2 with the single-stranded DNA-binding protein POT1 through the intermediary protein TPP1 (Khakzad2023A; Savage2008TINF2). This interaction is vital for the assembly and function of the shelterin complex, ensuring telomere integrity and preventing chromosomal instability (Savage2008TINF2).

TIN2 is involved in regulating telomerase activity by enhancing telomerase processivity, which is crucial for maintaining telomere length. It interacts with TPP1/POT1 to stimulate telomerase, facilitating the addition of telomeric repeats to chromosome ends (Pike2019TIN2). TIN2 also plays a role in telomere replication and replication fork progression, preventing replication fork stalling and activation of the DNA damage response (Pike2019TIN2).

In healthy cells, TIN2 helps maintain telomere stability, preventing genomic instability and the initiation of tumorigenesis. Its function is critical for chromosomal stability and cellular lifespan (He2020A).

## Clinical Significance
Mutations in the TINF2 gene are associated with a range of telomere biology disorders (TBDs), including dyskeratosis congenita, Høyeraal-Hreidarsson syndrome, and Revesz syndrome. These conditions are characterized by critically short telomeres, leading to bone marrow failure, skin abnormalities, and increased cancer risk (Savage2008TINF2; Revy2022Genetics). TINF2 mutations can be de novo and often result in rapid telomere shortening within a single generation (Khakzad2023A).

Truncation mutations in TINF2 are linked to inherited cancer predisposition, with a broad spectrum of cancers such as breast, colorectal, thyroid cancer, and melanoma. These mutations cause aberrant telomere elongation, which is associated with cancer development (He2020A; Schmutz2020TINF2). In contrast, missense mutations in the DC patch of TINF2 lead to bone marrow failure syndromes due to excessive telomere shortening (Schmutz2020TINF2).

The TINF2 gene is also implicated in autoimmune neutropenia and immune dysregulation, where mutations can lead to premature stem cell consumption and a spectrum of clinical manifestations, depending on the specific gene variant (Chianucci2022Autoimmune).

## Interactions
TINF2, a component of the shelterin complex, plays a crucial role in telomere maintenance by interacting with several key proteins. It binds to TRF1 and TRF2, forming stable complexes that are essential for telomere protection. The interaction with TRF1 is stronger than with TRF2, due to better structural compatibility, although TPP1 can enhance TRF2 binding by inducing allosteric changes in TINF2 (Janovič2018Human). TINF2 also interacts with TPP1, which is vital for the assembly of the shelterin complex and for stimulating telomerase processivity through the TPP1/POT1 complex (Pike2019TIN2).

Mutational analyses have shown that specific mutations in TINF2 can disrupt these interactions, leading to increased DNA damage signaling and telomere fusions. For instance, the A15R mutation disrupts the TINF2-TPP1 interaction, while L260E affects the TIN2-TRF1 interaction (Hu2017Structural). These interactions are crucial for preventing chromosome fusions and maintaining telomere integrity (Hu2017Structural). TINF2's interactions with TRF1 and TRF2 are also necessary for its localization to telomeres, highlighting its central role in telomere protection (Hu2017Structural).


## References


[1. (Khakzad2023A) Motahareh Khakzad, Zahra Shahbazi, Majid Naderi, and Morteza Karimipoor. A de novo tinf2, r282c mutation in a case of dyskeratosis congenital founded by next-generation sequencing. The Payam-e-Marefat-Kabul Education University, 27(2):146–151, March 2023. URL: http://dx.doi.org/10.61186/ibj.3783, doi:10.61186/ibj.3783. This article has 0 citations.](https://doi.org/10.61186/ibj.3783)

2. (Janovič2018Human) Human telomere repeat binding factor TRF1 replaces TRF2 bound to shelterin core hub TIN2 when TPP1 is absent. This article has 1 citations.

[3. (He2020A) Huiling He, Wei Li, Daniel F. Comiskey, Sandya Liyanarachchi, Taina T. Nieminen, Yanqiang Wang, Katherine E. DeLap, Pamela Brock, and Albert de la Chapelle. A truncating germline mutation of tinf2 in individuals with thyroid cancer or melanoma results in longer telomeres. Thyroid, 30(2):204–213, February 2020. URL: http://dx.doi.org/10.1089/thy.2019.0156, doi:10.1089/thy.2019.0156. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.1089/thy.2019.0156)

[4. (Chianucci2022Autoimmune) Benedetta Chianucci, Alice Grossi, Gianluca Dell’Orso, Elena Palmisani, Marina Lanciotti, Paola Terranova, Filomena Pierri, Michela Lupia, Luca Arcuri, Marica Laurino, Isabella Ceccherini, Fabian Beier, Carlo Dufour, Francesca Fioredda, and Maurizio Miano. Autoimmune neutropenia and immune-dysregulation in a patient carrying a tinf2 variant. International Journal of Molecular Sciences, 23(23):14535, November 2022. URL: http://dx.doi.org/10.3390/ijms232314535, doi:10.3390/ijms232314535. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms232314535)

[5. (Revy2022Genetics) Patrick Revy, Caroline Kannengiesser, and Alison A. Bertuch. Genetics of human telomere biology disorders. Nature Reviews Genetics, 24(2):86–108, September 2022. URL: http://dx.doi.org/10.1038/s41576-022-00527-z, doi:10.1038/s41576-022-00527-z. This article has 58 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41576-022-00527-z)

[6. (Hu2017Structural) Chunyi Hu, Rekha Rai, Chenhui Huang, Cayla Broton, Juanjuan Long, Ying Xu, Jing Xue, Ming Lei, Sandy Chang, and Yong Chen. Structural and functional analyses of the mammalian tin2-tpp1-trf2 telomeric complex. Cell Research, 27(12):1485–1502, November 2017. URL: http://dx.doi.org/10.1038/cr.2017.144, doi:10.1038/cr.2017.144. This article has 99 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/cr.2017.144)

[7. (Savage2008TINF2) Sharon A. Savage, Neelam Giri, Gabriela M. Baerlocher, Nick Orr, Peter M. Lansdorp, and Blanche P. Alter. Tinf2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. The American Journal of Human Genetics, 82(2):501–509, February 2008. URL: http://dx.doi.org/10.1016/j.ajhg.2007.10.004, doi:10.1016/j.ajhg.2007.10.004. This article has 331 citations.](https://doi.org/10.1016/j.ajhg.2007.10.004)

[8. (Pike2019TIN2) Alexandra M. Pike, Margaret A. Strong, John Paul T. Ouyang, and Carol W. Greider. Tin2 functions with tpp1/pot1 to stimulate telomerase processivity. Molecular and Cellular Biology, November 2019. URL: http://dx.doi.org/10.1128/mcb.00593-18, doi:10.1128/mcb.00593-18. This article has 36 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.00593-18)

[9. (Schmutz2020TINF2) Isabelle Schmutz, Arjen R Mensenkamp, Kaori K Takai, Maaike Haadsma, Liesbeth Spruijt, Richarda M de Voer, Seunga Sara Choo, Franziska K Lorbeer, Emma J van Grinsven, Dirk Hockemeyer, Marjolijn CJ Jongmans, and Titia de Lange. Tinf2 is a haploinsufficient tumor suppressor that limits telomere length. eLife, December 2020. URL: http://dx.doi.org/10.7554/elife.61235, doi:10.7554/elife.61235. This article has 32 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.61235)